skip to main content

Our Private Equity Group provides trusted counsel derived from deep industry knowledge to established as well as up-and-coming private equity firms. We represent firms of every size across the spectrum of investment strategies, and we build long-standing relationships with our clients. As active participants in the private equity industry, we are able to advise our clients on the latest innovations, as well as current market practices and trends.

AVCJ Names Paul, Weiss Transaction "Deal of the Week"

In its April 17 issue, Asian Venture Capital Journal named KKR China Healthcare Investment Limited's (KKR) investment in China Cord Blood Corporation (CCBC) "Deal of the Week." KKR and CCBC, the largest cord blood banking operator in China, entered into a purchase agreement for an issuance to KKR of $65 million principal amount of notes convertible into CCBC common stock.

CCBC was listed on the New York Stock Exchange in 2009 and was the first licensed cord blood banking operator in China. The investment will be used to support CCBC's business expansion and to capitalize on China's fast growing healthcare services industry.

Paul, Weiss represented KKR in this transaction. The Paul, Weiss team included partners John E. (Jack) Lange, Mark S. Bergman, Tracey Zaccone, Mark F. Mendelsohn and David R. Sicular and counsel Richard S. Elliott.

April 17, 2012

© 2021 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy